Home » Topics » BioWorld Science

BioWorld Science
RSS

Moleculin Biotech enters agreement to develop formulation for its STAT3 inhibitor

June 7, 2018

Alkermes receives payment from Biogen related to BIIB-098 program

June 7, 2018

Intra-Cellular initiates rolling submission of NDA for lumateperone

June 7, 2018

FDA grants rare pediatric disease designation to CLR-131 for the treatment of rhabdomyosarcoma

June 7, 2018

Microbiotica and Genentech enter strategic collaboration for IBD

June 7, 2018

Virpax signs license agreement to use LipoCure's liposome drug delivery technology

June 7, 2018

First patient enrolled in phase IIa study of THX-110

June 6, 2018

Merck & Co. describes DGAT-2 inhibitors

June 6, 2018

Cognition Therapeutics doses first patient in SNAP study of Elayta

June 6, 2018

Amgen identifies new apelin receptor agonists

June 6, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...